Skip to content
10-Q

Quarterly Report

Milestone Scientific Inc. MLSS

0001493152-26-022701

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 88.08M sh
Shares Diluted Q1 2026 · Mar 31, 2026 85.04M sh
Shares Diluted Q1 2026 · Mar 31, 2025 81.85M sh
Capex Q1 2026 · Mar 31, 2026 $1.63K
Capex Q1 2026 · Mar 31, 2025 $1.3K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $86.84K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.01M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.2M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.1M
Stockholders Equity Q1 2026 · Mar 31, 2026 $2.28M
Stockholders Equity Q1 2026 · Dec 31, 2025 $2.81M
Stockholders Equity Q1 2026 · Mar 31, 2025 $4.46M
Stockholders Equity Q1 2026 · Dec 31, 2024 $5.83M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.86M
Current Liabilities Q1 2026 · Dec 31, 2025 $4.13M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.68M
Total Liabilities Q1 2026 · Dec 31, 2025 $4.99M
Current Assets Q1 2026 · Mar 31, 2026 $7.35M
Current Assets Q1 2026 · Dec 31, 2025 $7.48M
Total Assets Q1 2026 · Mar 31, 2026 $7.96M
Total Assets Q1 2026 · Dec 31, 2025 $7.81M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.01
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.02
Eps Basic Q1 2026 · Mar 31, 2026 −$0.01
Eps Basic Q1 2026 · Mar 31, 2025 −$0.02
Sga Expense Q1 2026 · Mar 31, 2026 $2.37M
Sga Expense Q1 2026 · Mar 31, 2025 $3.26M
Net Income Q1 2026 · Mar 31, 2026 −$839.85K
Net Income Q1 2026 · Mar 31, 2025 −$1.99M
Operating Income Q1 2026 · Mar 31, 2026 −$828.08K
Operating Income Q1 2026 · Mar 31, 2025 −$2M
Gross Profit Q1 2026 · Mar 31, 2026 $1.56M
Gross Profit Q1 2026 · Mar 31, 2025 $1.65M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $598.01K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $584.99K
Rd Expense Q1 2026 · Mar 31, 2025 $369.12K